CEBPB and cancer: We identify here key TF, namely AP-1, C/EBPβ, and PU.140–42, all previously linked to lineage-aberrant phenotypes in hematologic malignancies32,43–45, as main drivers of senescence-associated myeloid-biased cancer cell cross-differentiation.